Description
Clinical studies have shown that the use of a 46.7% Sodium Citrate solution to lock indwelling catheters has significant advantages compared to existing standards of care.
46.7% CitraFlow™ is a proven antimicrobial for reducing the rates of Central Line Associated Blood Stream Infections (CLABSIs).
